147 related articles for article (PubMed ID: 7945256)
1. Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum.
Rogers MJ; Ji X; Russell RG; Blackburn GM; Williamson MP; Bayless AV; Ebetino FH; Watts DJ
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):303-11. PubMed ID: 7945256
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes.
Rogers MJ; Brown RJ; Hodkin V; Blackburn GM; Russell RG; Watts DJ
Biochem Biophys Res Commun; 1996 Jul; 224(3):863-9. PubMed ID: 8713136
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth of Dictyostelium discoideum amoebae by bisphosphonate drugs is dependent on cellular uptake.
Rogers MJ; Xiong X; Ji X; Mönkkönen J; Russell RG; Williamson MP; Ebetino FH; Watts DJ
Pharm Res; 1997 May; 14(5):625-30. PubMed ID: 9165534
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum.
Rogers MJ; Watts DJ; Russell RG; Ji X; Xiong X; Blackburn GM; Bayless AV; Ebetino FH
J Bone Miner Res; 1994 Jul; 9(7):1029-39. PubMed ID: 7942149
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of halogenated bisphosphonates by the cellular slime mould Dictyostelium discoideum.
Rogers MJ; Russell RG; Blackburn GM; Williamson MP; Watts DJ
Biochem Biophys Res Commun; 1992 Nov; 189(1):414-23. PubMed ID: 1333194
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
Rogers MJ; Xiong X; Brown RJ; Watts DJ; Russell RG; Bayless AV; Ebetino FH
Mol Pharmacol; 1995 Feb; 47(2):398-402. PubMed ID: 7870050
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of dichloromethane diphosphonate and of 1-hydroxyethane-1,1-diphosphonate in the amoebae of the slime mould Dictyostelium discoideum. A 31P NMR study.
Pelorgeas S; Martin JB; Satre M
Biochem Pharmacol; 1992 Dec; 44(11):2157-63. PubMed ID: 1472080
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum.
Brown RJ; van Beek E; Watts DJ; Löwik CW; Papapoulos SE
J Bone Miner Res; 1998 Feb; 13(2):253-8. PubMed ID: 9495518
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
[TBL] [Abstract][Full Text] [Related]
10. Aminoacyl-tRNA synthetases catalyze AMP----ADP----ATP exchange reactions, indicating labile covalent enzyme-amino-acid intermediates.
Rapaport E; Remy P; Kleinkauf H; Vater J; Zamecnik PC
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7891-5. PubMed ID: 2960970
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the chemistry and biological activity of the bisphosphonates.
Ebetino FH; Hogan AM; Sun S; Tsoumpra MK; Duan X; Triffitt JT; Kwaasi AA; Dunford JE; Barnett BL; Oppermann U; Lundy MW; Boyde A; Kashemirov BA; McKenna CE; Russell RG
Bone; 2011 Jul; 49(1):20-33. PubMed ID: 21497677
[TBL] [Abstract][Full Text] [Related]
12. An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs.
Szabo CM; Martin MB; Oldfield E
J Med Chem; 2002 Jul; 45(14):2894-903. PubMed ID: 12086477
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of transfer RNAs from Dictyostelium discoideum during growth and development.
Palatnik CM; Katz ER
J Biol Chem; 1977 Jan; 252(2):694-703. PubMed ID: 556726
[TBL] [Abstract][Full Text] [Related]
14. A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates.
Mönkkönen H; Auriola S; Lehenkari P; Kellinsalmi M; Hassinen IE; Vepsäläinen J; Mönkkönen J
Br J Pharmacol; 2006 Feb; 147(4):437-45. PubMed ID: 16402039
[TBL] [Abstract][Full Text] [Related]
15. From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates.
Rogers MJ
Calcif Tissue Int; 2004 Dec; 75(6):451-61. PubMed ID: 15332174
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of action of bisphosphonates: current status.
Roelofs AJ; Thompson K; Gordon S; Rogers MJ
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6222s-6230s. PubMed ID: 17062705
[TBL] [Abstract][Full Text] [Related]
17. Differentiation-inducing factor from the slime mould Dictyostelium discoideum and its analogues. Synthesis, structure and biological activity.
Masento MS; Morris HR; Taylor GW; Johnson SJ; Skapski AC; Kay RR
Biochem J; 1988 Nov; 256(1):23-8. PubMed ID: 3223901
[TBL] [Abstract][Full Text] [Related]
18. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates.
van beek E; Löwik C; van der Pluijm G; Papapoulos S
J Bone Miner Res; 1999 May; 14(5):722-9. PubMed ID: 10320520
[TBL] [Abstract][Full Text] [Related]
19. Cytokinin oxidase activity in the cellular slime mold, Dictyostelium discoideum.
Armstrong DJ; Firtel RA
Dev Biol; 1989 Dec; 136(2):491-9. PubMed ID: 2555236
[TBL] [Abstract][Full Text] [Related]
20. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
